Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Change in Cash (2016 - 2025)

Historic Change in Cash for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$30.9 million.

  • Accendra Health's Change in Cash rose 8441.32% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.9 million, marking a year-over-year increase of 8347.86%. This contributed to the annual value of -$223.5 million for FY2024, which is 21970.83% down from last year.
  • Per Accendra Health's latest filing, its Change in Cash stood at -$30.9 million for Q3 2025, which was up 8441.32% from $17.7 million recorded in Q2 2025.
  • Accendra Health's 5-year Change in Cash high stood at $225.9 million for Q2 2023, and its period low was -$198.4 million during Q3 2024.
  • Over the past 5 years, Accendra Health's median Change in Cash value was -$3.0 million (recorded in 2023), while the average stood at -$4.6 million.
  • As far as peak fluctuations go, Accendra Health's Change in Cash crashed by 161643.41% in 2022, and later surged by 57201.88% in 2025.
  • Accendra Health's Change in Cash (Quarter) stood at $16.0 million in 2021, then plummeted by 144.02% to -$7.0 million in 2022, then skyrocketed by 424.13% to $22.8 million in 2023, then plummeted by 212.93% to -$25.7 million in 2024, then decreased by 20.28% to -$30.9 million in 2025.
  • Its Change in Cash stands at -$30.9 million for Q3 2025, versus $17.7 million for Q2 2025 and $10.1 million for Q1 2025.